Found 8 matching trials
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
EARLY_PHASE1This is a single-arm, open-label, phase I clinical study to evaluate the sa...
Location
Nanjing Children's Hospital
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD
PHASE1This is an open label, Multi-center,dose-escalation study in up to 18 parti...
Location
Multiple Locations
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
EARLY_PHASE1This single-arm, open-label investigator-initiated trial (IIT) evaluates th...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Universal CAR-T Cell Therapy for Refractory Lupus Nephritis
EARLY_PHASE1This investigator-initiated trial aims to assess the efficacy and safety of...
Location
Multiple Locations
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
EARLY_PHASE1This is an open-label, Phase I, investigator-initiated trial (IIT) designed...
Location
Union Hospital, Tongji Medical College, Huazhong Univerdity of Science and Technology
Universal CAR-T Cells Targeting Multiple Myeloma
PHASE1The aim of this study is to assess the feasibility, safety and efficacy of ...
Location
Shenzhen Geno-Immune Medical Institute
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
EARLY_PHASE1An Exploratory, Single-Arm, Open-Label, Dose-Escalation Study of the Safety...
Location
Zhongshan Hospital, Fudan University